Effects of Intravenous (IV) Omadacycline on Gut Microbiome

Inclusion Criteria: * 18-40 years of age * Willing and able to comply with all study procedures * Considered healthy without history of cardiovascular, gastrointestinal, hepatic, or renal disease * males or females - females of child bearing potential must agree to use a highly effective contraception during the study and for at least 7 days after the last dose of omadacycline Exclusion Criteria: * Consumed probiotics within 30 days before enrollment * Consumed antibiotics within 90 days prior to enrollment * Known hypersensitivity to omadacycline or tetracycline-class antibiotics * pregnant or breastfeeding * in the opinion of the investigator is experiencing signs or symptoms of acute illness that increase the risk of adverse effects from participating in the study * previously participated in the study